Kanda Kiyoko
Graduate School of Health Sciences, Gunma University.
Gan To Kagaku Ryoho. 2017 Jul;44(7):545-549.
Number of people who handle anticancer drugs in their profession is increasing. Anticancer drugs, which are hazardous drugs(HD), exert cytocidal effects on cancer cells, but many have also been shown to have mutagenicity, teratogenicity and carcinogenicity; therefore, safe handling of anticancer drugs is necessary. In July 2015, the first Japanese guidelines for exposure control measures, namely, the "Joint Guidelines for Safe Handling of Cancer Chemotherapy Drugs", were published jointly by 3 societies. Our guideline is the creation of the Japanese Society of Cancer Nursing(JSCN), Japanese Society of Medical Oncology(JSMO)and Japanese Society of Pharmaceutical Oncology(JASPO)and has a historical significance. This paper states the necessity of safe handling of anticancer drugs, Japan's recent movement of safe handling, the introduction of joint guidelines of safe handling of anticancer drugs, and new movement of safe handling of USP chapter 800 in the United States.
从事抗癌药物处理工作的人数正在增加。抗癌药物属于危险药物(HD),对癌细胞具有杀细胞作用,但许多抗癌药物也已被证明具有致突变性、致畸性和致癌性;因此,安全处理抗癌药物是必要的。2015年7月,日本首个暴露控制措施指南,即《癌症化疗药物安全处理联合指南》由3个学会联合发布。我们的指南由日本癌症护理学会(JSCN)、日本医学肿瘤学会(JSMO)和日本药物肿瘤学会(JASPO)制定,具有历史意义。本文阐述了安全处理抗癌药物的必要性、日本近期的安全处理动态、抗癌药物安全处理联合指南的介绍以及美国USP第800章安全处理的新动态。